Sign up Australia
Proactive Investors - Run By Investors For Investors

Respiri enters partnership to develop next generation breath sensors

Respiri’s flagship product connects with a smartphone to detect and measure wheeze.
a smartphone
Respiri's products have been cleared by the U.S. FDA

Respiri Ltd (ASX:RSH) has entered into a partnership with Grey Innovation to develop the next generation of its “AirSonea” breath sensor with a new creative design and superior ergonomics.

The company’s shares closed 17% higher on Tuesday, at $0.034.

Respiri is a health technology player focused on developing innovative devices and mobile health apps to improve the management of chronic and costly respiratory disorders.

The company’s new partner Grey Innovation is a commercialisation technology company based in Melbourne, which is working with universities and research institutes in Australia and Germany.

Respiri has partnered with Grey Innovation to ensure fast completion and low execution risk for the upgraded breath sensor.

Respiri’s flagship product AirSonea is an easy-to-use device that connects via Bluetooth with a sophisticated smartphone app to detect and measure wheeze.

The company has a first-mover advantage in providing broad access to its proprietary acoustic based clinical solutions for remote monitoring using over-the-counter connected devices.

Respiri products have been cleared for use by the U.S. FDA, the European Union, the Australian TGA and the commencement of an approval process for Asian markets has begun.

View full RSH profile View Profile

Respiri Ltd Timeline

Newswire
June 04 2015

Related Articles

1510629376_Agent-Reality-and-Sweep.JPG
November 16 2017
Thred's Geoff Marshall at Proactive's CEO Sessions in Melbourne and Sydney.
picture of trading screens
November 30 2017
Tavistock’s optimism is based on the surge of money into its seven discretionary funds that trade under the Acumen brand.
9 Spokes smart phone screen
April 03 2018
The onboarding rate of small business onto the platform continues to accelerate as banking partners adoption increases.

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use